Policy & RegulationAnalysis

China Outlines Healthcare Security Priorities for 15th Five-Year Plan

Regulators outline goals for reimbursement access and coordinated health sector governance ahead of the upcoming planning cycle.

Share
A security guard operates a wheelchair lift on a van outside a medical facility.
Photo by DΛVΞ GΛRCIΛ on Pexels

The Brief

Chinese health insurance authorities have outlined development priorities for the country's medical security system during the upcoming 15th Five-Year Plan period. Speaking at a State Council Information Office press briefing, representatives from the National Healthcare Security Administration highlighted core objectives, including safeguarding public reimbursement for outpatient care and pharmaceuticals while strengthening coordinated governance across healthcare providers, insurance funds, and pharmaceutical supply chains.

Why it matters

China's basic medical insurance system covers the vast majority of the country's population, making policy shifts directly relevant to household healthcare costs and pharmaceutical market dynamics. Early planning signals indicate how authorities intend to balance fund sustainability with public access to medical care.

China context

A central pillar of China's ongoing healthcare reform is the coordinated development and governance of medical services, medical insurance, and the pharmaceutical sector, commonly referred to as the 'three-medical linkage'. Aligning these three components is critical to curbing wasteful clinical expenditure, rationalizing drug pricing, and ensuring the long-term solvency of regional and national insurance pools.

Editor's View

EDITOR'S VIEW — Analysis and inference, not factual reporting. The National Healthcare Security Administration's early focus on system coordination underscores the persistent fiscal and demographic pressures facing China's universal health coverage model. With an aging society and rising chronic disease burdens, insurance authorities must maintain high coverage rates while containing structural costs. The emphasis on linking insurance reimbursement with hospital operations and drug procurement suggests that regulatory scrutiny over clinical prescribing patterns, procurement pricing, and fund management will remain tight throughout the next planning cycle.

What to watch

  • Publication of the formal 15th Five-Year Plan for healthcare security and accompanying regulatory guidelines
  • Further policy adjustments regarding cross-provincial direct settlement and national bulk procurement of pharmaceuticals and consumables
  • Implementation of hospital payment method reforms, such as DRG and DIP systems, across local jurisdictions

Key Takeaways

  • 1The State Council Information Office hosted a briefing on healthcare security priorities for the 15th Five-Year Plan period.
  • 2National Healthcare Security Administration officials highlighted the protection of public reimbursements for medical care and pharmaceuticals as a core priority.
  • 3Regulators stressed the coordinated governance and development of healthcare services, medical insurance, and pharmaceutical administration.
Officials from China's National Healthcare Security Administration have set out the preliminary direction for the country's medical security system during the upcoming 15th Five-Year Plan period, according to reporting by Xinhua. The framework was presented during a press briefing organized by the State Council Information Office as part of a series focused on the launch of the 15th Five-Year Plan. At the event, healthcare security officials addressed key public concerns regarding medical care access, drug purchases, and reimbursement coverage. A central focus of the development blueprint is improving the reliability and scope of patient reimbursements for healthcare services and prescribed medications. Officials indicated that the upcoming planning period will prioritize maintaining effective financial protection for citizens seeking medical care. In addition to reimbursement mechanisms, the agency highlighted the need to advance coordinated governance across medical services, health insurance, and pharmaceutical administration. This structural coordination, known in domestic reform terminology as the 'three-medical' linkage, aims to align healthcare provider incentives with insurance fund preservation and pharmaceutical market efficiency. While the preliminary briefing outlined the broad strategic vision for the sector, specific numeric targets, financial allocations, and detailed reform measures have not yet been made public. Further technical guidelines and sectoral master plans are expected to be released as planning for the 15th Five-Year Plan progresses.